Statin Prescribing
Cross-source consensus on Statin Prescribing from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Evidence quality
Highlighted claims
- Less than half of the full cohort received guideline-recommended statin therapy. — Statin prescription rates for prevention of atherosclerotic cardiovascular disease in adults 40–75 years old with type 1 diabetes
- Nearly half of the cohort was not prescribed any statin. — Statin prescription rates for prevention of atherosclerotic cardiovascular disease in adults 40–75 years old with type 1 diabetes
- Among patients with ASCVD, only 39.3% received high-intensity guideline-directed statin therapy. — Statin prescription rates for prevention of atherosclerotic cardiovascular disease in adults 40–75 years old with type 1 diabetes
- Among patients without ASCVD, 44.3% received guideline-directed moderate- or high-intensity statins. — Statin prescription rates for prevention of atherosclerotic cardiovascular disease in adults 40–75 years old with type 1 diabetes